AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Price to FCF (2020 - 2023)

Updated

AbCellera Biologics' Price to FCF came in at 34.92 for Q1 2023, up 108.9% from 16.72 a year earlier and up 147.1% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Price to FCF (2020 - 2023) Analysis & Trends

For FY2022, AbCellera Biologics' Price to FCF was 14.14, down 35.0% from FY2021.

  • Going back by year, Price to FCF was 21.76 in FY2021 (-95.6%) and 492.13 in FY2020.
  • The Q1 2023 figure represents the highest quarterly Price to FCF since Q1 2021.
  • Year-over-year, Price to FCF increased in 1 of the last six quarters, with an average decline of 32.7%.
  • Business Quant data shows ABCL's Price to FCF at 14.14 (Q4 2022), 17.45 (Q3 2022) and 10.59 (Q2 2022) in the three quarters before Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 AbCellera Biologics 3.89 Bn 3.89 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 34.92
Dec 31, 2022 14.14
Sep 30, 2022 17.45
Jun 30, 2022 10.59
Mar 31, 2022 16.72
Dec 31, 2021 21.76
Sep 30, 2021 26.57
Jun 30, 2021 27.84
Mar 31, 2021 76.50
Dec 31, 2020 492.13
API Access

AbCellera Biologics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=ABCL&period=max&api_key=YOUR_API_KEY